Study of the Impact of a Targeted Decolonization of S. Aureus Persistent

Status Recruiting

Clinical Trial Summary

S. aureus nasal carriage is a well-known risk factor for S. aureus infections in hemodialysis (HD) patients. Strains of carriage and infections are the same in >80% of cases We recently shown that persistent carriers of S. aureus, not intermittent ones are at increased risk of staphylococcal infections in HD. Thanks to a new algorithm developped based on one nasal sample the determination of carriage status (persistent, intermittent or non-carriers) among patients is easy. Mupirocin use in HD have been shown to reduce significantly S. aureus infections however, multiples schedules of decolonization have been proposed to all S. aureus carriers. To date, there is no national guideline for decolonization of S. aureus in HD. We showed that only 50% of HD centers in France propose screening and decolonization of S. aureus carriers. The aim of the study is therefore to evaluate the impact of a targeted decolonization of S. aureus persistent carriers using mupirocin nasal ointment and chlorhexidine baths during 5 days on the occurrence of S. aureus infections in HD patients compared to the absence of decolonization using a randomized open study methodology.

Clinical Trial Description

Hemodialysis patients will be randomized in 2 arms: one arm where persistent carriers will be decolonized. Decolonization schedule associate the use of mupirocin nasal ointment 3 times a day and chlorhexidine bath once a day for 5 days. Screening of persistent carriers in this arm will be done every 3 months and a new decolonization will be proposed to patients found (again) persistent carriers. Determination of carriage status will be done using one nasal swab by following the algorithm previously described. Bacterial load will be determined by a quantitative S. aureus PCR (Polymerase Chain Reaction) : persistent carriers are the patient with a bacterial load > 103 CFU/mL (Colony Forming Unit) . The other arm is HD patients in which decolonization is not performed including impersistent carriers. All infections that occurred in enrolled patients will be counted in both groups ;

Study Design

Related Conditions & MeSH terms

Hemodialysis Patients

Clinical Trial Details

NCT number	NCT02945722
Study type	Interventional
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact	Elisabeth Botelho-Nevers, MD PhD
Phone	(0)477829234
Email	elisabeth.botelho-nevers@chu-st-etienne.fr
Status	Recruiting
Phase	Phase 4
Start date	February 23, 2018
Completion date	October 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06382701` - Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation	N/A
Completed	`NCT04674930` - Effects of Exercise Program on Physical Functioning of Hemodialysis Patients.	N/A
Recruiting	`NCT02245633` - Correlation Between Vitamin D Levels to ADAMTS13 , VWF and Micro RNA Expression in Diabetic Hemodialysis Patients	N/A
Recruiting	`NCT01970280` - Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.	Phase 4
Completed	`NCT06165211` - Nature-Based Sound Application For Hemodialysis Patients	N/A
Completed	`NCT06106763` - Mandala Colouring On Anxiety, Depression, Pain And Quality of Life	N/A
Completed	`NCT05693584` - The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients	N/A
Completed	`NCT01932853` - Association Between Dose Dialysis by Kt and Mortality	N/A
Completed	`NCT01273974` - The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients	Phase 2/Phase 3
Completed	`NCT04139759` - THE EFFECT OF HAND AND FOOT MASSAGE ON FATIGUE IN HEMODIALYSIS PATIENTS	N/A
Not yet recruiting	`NCT05574595` - Effect on Pain and Comfort Associated With Fistula Puncture	N/A
Completed	`NCT04175652` - Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality	N/A
Not yet recruiting	`NCT06314243` - The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients	Phase 3
Completed	`NCT01596842` - Effect of Omega-3 Fatty Acid on Vitamin D Activation	Phase 4
Enrolling by invitation	`NCT01896882` - Dietary Sodium Restriction in Hemodialysis Patients	N/A
Completed	`NCT00638300` - Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)	N/A
Terminated	`NCT00259714` - Dialysate Sodium Individualization in Hemodialysis	Phase 1
Completed	`NCT01846754` - Prevalence of Fatigue in Hemodialysis Patients	N/A
Completed	`NCT00491868` - Clinical Study of R744 to Hemodialysis Patients	Phase 3
Completed	`NCT04195919` - The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers — CIBERSTAPH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms